Skip to main content

Table 1 The antinuclear antibodies indexes of two SLE patients at different time points

From: Short-term assessment of BCR repertoires of SLE patients after high dose glucocorticoid therapy with high-throughput sequencing

Antinuclear antibodies P1 P2
Anti-nRNP/SM 3+, 2+, 2+ 3+, 2+, 1+
Anti-SM N, N, N 2+, 1+, N
Anti-SSA 3+, 3+, 3+ 3+, 3+, 3+
Anti-RO-52 N, N, N 3+, 3+, 3+
Anti-SSB N, N, N 1+, N, N
Anti-SCOL-70 N, N, N N, N, N
Anti-JO-1 N, N, N N, N, N
Anti-CENP B N, N, N N, N, N
Anti-dsDNA 3+, 2+, 2+ 1+, N, N
Anti-nucleosome 3+, 3+, 3+ N, N, N
Anti-histone 3+, 1+, 1+ N, N, N
Anti-ribosomal P N, N, N 3+, 3+, 2+
ACA N, N, N N, N, N
  1. The “N” represents negative result, the “1+” represents weakly positive result, “2+” represents positive result, “3+” represents strong positive result